Guillain-Barre Syndrome: Demographics, Clinical Profile & Seasonal Variation in a Tertiary Care Centre of Central India

Overview

Journal Indian J Med Res

Specialty General Medicine

Date 2017 Jun 23

PMID 28639596

Citations 13

Authors

Manisha Shrivastava

Shah Nehal

Navaid Seema

Affiliations

Soon will be listed here.

Abstract

Background & Objectives: Guillain-Barre syndrome (GBS) is an autoimmune disease and a recognized cause of generalized progressive paralysis worldwide. The present study was aimed to document the clinical findings, demographics and seasonal variations amongst the patients with GBS during the hospital stay.

Methods: A retrospective analysis of 66 referred cases diagnosed as GBS was conducted. Medical records and the data related to age, sex, antecedent illness, duration of symptoms before admission, muscle power graded by the Medical Research Council scale, functional scores, details of Intensive Care Unit complications and need for ventilation were obtained. The patients were divided into four seasonal groups: S1 (spring, February to April), S2 (summer, May to July), S3 (rainy, August to October) and S4 (winter, November to January) and parameters were studied.

Results: The mean age of the patients was 40.69 yr. Forty one (62.1%) patients had a history of preceding illness. Forty nine (74.2%) patients showed quadriparesis as most common complaint. Thirty three (50%) patients were of acute inflammatory demyelinating polyneuropathy (AIDP) variant. The highest number of GBS cases (60%) was found in S1 and S2. The maximum duration of hospital stay was observed in S3 group (mean 23 days).

Interpretation & Conclusions: GBS seems to affect all age groups with male preponderance. Most common antecedent event and presenting feature were flu-like illness and quadriparesis, respectively. AIDP was the most common variant. Most cases occurred from February to July (S1 and S2 group) (maximum in July) with preceding influenza and diarrhoea and maximum duration of hospital stay was observed in S3 group. Prospective studies with follow up of GBS patients need to be done to confirm findings.

Citing Articles

Clinical characteristics of Guillain-Barré syndrome in Shenzhen: a retrospective study.

Guo F, Yao Q, Wu X, Guo H, Su X, Zhou J BMC Neurol. 2025; 25(1):72.

PMID: 39984908 PMC: 11844154. DOI: 10.1186/s12883-025-04061-3.

Characteristics and outcomes of patients with Guillain-Barré syndrome who were admitted to the intensive care unit: a retrospective observational study.

Alqahtani S, Al-Dorzi H, Arishi H, Peeran A, Humaid F, Alenezi F J Int Med Res. 2024; 52(12):3000605241306655.

PMID: 39719074 PMC: 11683809. DOI: 10.1177/03000605241306655.

Variation in worldwide incidence of Guillain-Barré syndrome: a population-based study in urban China and existing global evidence.

Xu L, Zhao C, Bao Y, Liu Y, Liang Y, Wei J Front Immunol. 2024; 15:1415986.

PMID: 39318625 PMC: 11420027. DOI: 10.3389/fimmu.2024.1415986.

A pathologically expanded, clonal lineage of IL-21-producing CD4+ T cells drives inflammatory neuropathy.

Seyedsadr M, Bang M, McCarthy E, Zhang S, Chen H, Mohebbi M J Clin Invest. 2024; 134(15).

PMID: 39087473 PMC: 11290969. DOI: 10.1172/JCI178602.

A retrospective analysis of the clinical profile and factors associated with mortality and poor hospital outcomes in adult Guillain-Barre syndrome patients.

Tewedaj Z, Huluka D, Kebede Y, Abebe A, Hussen M, Mohammed B Sci Rep. 2024; 14(1):15520.

PMID: 38969647 PMC: 11226644. DOI: 10.1038/s41598-024-65265-0.

References

Sharma A, Lal V, Modi M, Vaishnavi C, Prabhakar S . Campylobacter jejuni infection in Guillain-Barré syndrome: a prospective case control study in a tertiary care hospital. Neurol India. 2011; 59(5):717-21. DOI: 10.4103/0028-3886.86547. View

Gupta D, Deepak G, Nair M, Muraleedharan N, Baheti N, Sarma P . Electrodiagnostic and clinical aspects of Guillain-Barré syndrome: an analysis of 142 cases. J Clin Neuromuscul Dis. 2009; 10(2):42-51. DOI: 10.1097/CND.0b013e31818e9510. View

Raphael J, Chevret S, Hughes R, Annane D . Plasma exchange for Guillain-Barré syndrome. Cochrane Database Syst Rev. 2012; (7):CD001798. DOI: 10.1002/14651858.CD001798.pub2. View

Sivadon-Tardy V, Orlikowski D, Porcher R, Sharshar T, Durand M, Enouf V . Guillain-Barré syndrome and influenza virus infection. Clin Infect Dis. 2008; 48(1):48-56. DOI: 10.1086/594124. View

van Doorn P, Ruts L, Jacobs B . Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome. Lancet Neurol. 2008; 7(10):939-50. DOI: 10.1016/S1474-4422(08)70215-1. View

Nachamkin I, Arzarte Barbosa P, Barbosa P, Ung H, Ung H, Lobato C . Patterns of Guillain-Barre syndrome in children: results from a Mexican population. Neurology. 2007; 69(17):1665-71. DOI: 10.1212/01.wnl.0000265396.87983.bd. View

McGrogan A, Madle G, Seaman H, de Vries C . The epidemiology of Guillain-Barré syndrome worldwide. A systematic literature review. Neuroepidemiology. 2008; 32(2):150-63. DOI: 10.1159/000184748. View

Hughes R, Swan A, Raphael J, Annane D, van Koningsveld R, van Doorn P . Immunotherapy for Guillain-Barré syndrome: a systematic review. Brain. 2007; 130(Pt 9):2245-57. DOI: 10.1093/brain/awm004. View

van Koningsveld R, Rico R, Gerstenbluth I, Schmitz P, Ang C, Merkies I . Gastroenteritis-associated Guillain-Barré syndrome on the Caribbean island Curaçao. Neurology. 2001; 56(11):1467-72. DOI: 10.1212/wnl.56.11.1467. View

10.

Orlikowski D, Prigent H, Sharshar T, Lofaso F, Raphael J . Respiratory dysfunction in Guillain-Barré Syndrome. Neurocrit Care. 2005; 1(4):415-22. DOI: 10.1385/NCC:1:4:415. View

11.

Kannan M, Ch R, Jabeen S, Mridula K, Rao P, Borgohain R . Clinical, electrophysiological subtypes and antiganglioside antibodies in childhood Guillain-Barré syndrome. Neurol India. 2011; 59(5):727-32. DOI: 10.4103/0028-3886.86549. View

12.

Kaya E, Keklik M, Sencan M, Yilmaz M, Keskin A, Kiki I . Therapeutic plasma exchange in patients with neurological diseases: multicenter retrospective analysis. Transfus Apher Sci. 2013; 48(3):349-52. DOI: 10.1016/j.transci.2013.04.015. View

13.

Hughes R, Wijdicks E, Benson E, Cornblath D, Hahn A, Meythaler J . Supportive care for patients with Guillain-Barré syndrome. Arch Neurol. 2005; 62(8):1194-8. DOI: 10.1001/archneur.62.8.1194. View

14.

Burns T . Guillain-Barré syndrome. Semin Neurol. 2008; 28(2):152-67. DOI: 10.1055/s-2008-1062261. View

15.

Rees J, Soudain S, Gregson N, Hughes R . Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med. 1995; 333(21):1374-9. DOI: 10.1056/NEJM199511233332102. View

16.

Larsen J, Kvale G, Nyland H . Epidemiology of the Guillain-Barré syndrome in the county of Hordaland, Western Norway. Acta Neurol Scand. 1985; 71(1):43-7. DOI: 10.1111/j.1600-0404.1985.tb03165.x. View

17.

Winer J, Hughes R, Greenwood R, Perkin G, Healy M . Prognosis in Guillain-Barré syndrome. Lancet. 1985; 1(8439):1202-3. DOI: 10.1016/s0140-6736(85)92875-2. View

18.

Kalita J, Misra U, Goyal G, Das M . Guillain-Barré syndrome: subtypes and predictors of outcome from India. J Peripher Nerv Syst. 2014; 19(1):36-43. DOI: 10.1111/jns5.12050. View

19.

Haghighi A, Banihashemi M, Zamiri N, Sabayan B, Heydari S, Safari A . Seasonal variation of Guillain-Barré syndrome admission in a large tertiary referral center in southern Iran: a 10 year analysis. Acta Neurol Taiwan. 2012; 21(2):60-3. View

20.

Islam Z, Jacobs B, van Belkum A, Mohammad Q, Islam M, Herbrink P . Axonal variant of Guillain-Barre syndrome associated with Campylobacter infection in Bangladesh. Neurology. 2010; 74(7):581-7. DOI: 10.1212/WNL.0b013e3181cff735. View